Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Cancer Prev Res (Phila). 2013 Jul 15;6(9):959–970. doi: 10.1158/1940-6207.CAPR-13-0087

Figure 4. Effects of BXL0124, CDDO-Im and the combination on the mRNA levels of ErbB family receptors and their ligands in MMTV-ErbB2/neu mammary tumors.

Figure 4

(A) The mRNA expression levels of ErbB family receptors, ErbB2, ErbB1 and ErbB3 in MMRV-ErbB2/neu mammary tumors were determined by qPCR (n=6) (B) The mRNA expression levels of ErbB ligands, EGF, HB-EGF and Nrg2 in MMTV-ErbB2/neu mammary tumors were determined by qPCR (n=6). Data is presented as mean ± S.E. Statistical significance was determined by ANOVA with Dunnett's adjustment (* p<0.05, ** p<0.01).